Protein Production Technology Podcast · FPG Media

Episode 30: Patents on a Plate: Protecting Innovation in Alternative Proteins In Partnership with Mathys & Squire

·1 hr 5 min·4 clips

Chris Hamer says sensory claims only work when the data is credible, reproducible, and standardized.

The show frames the discussion around patents as a commercial tool for alternative proteins. The host sets up the issue as protecting innovation across the value chain, from early R&D to commercial launch, and the guests respond with a grounded look at how claims work in a crowded patent landscape. Process claims are a major focus. The panel asks whether they still carry broad value today, and the answer is yes, especially when a company needs a set of rights it can use with third parties to license technology or support commercialization. Technical benefit matters. The discussion makes clear that an examiner is more likely to engage with broad claims when the invention shows a real-world technical advantage that reads as practical rather than theoretical. Novelty is tougher. Because fermentation and related protein technologies have a long trail of published research behind them, the conversation shifts to the risk of overlapping with older scientific papers, patents, and other public disclosures. Prior art matters. Laura describes a practical search process in which specialized firms can look through patents, applications, publications, and websites to surface relevant disclosures before a patent attorney evaluates the results. That search can save time. It helps innovators judge whether they are actually meeting the threshold of novelty and obviousness instead of learning too late that the idea was already disclosed in some earlier form. The tone stays measured. Rather than turning the topic into a legal lecture, the exchange keeps returning to the commercial stakes, including licensing, product protection, and the limits of trying to do everything alone in a global market. Scale keeps coming up. The speakers treat intellectual property as part of the same set of decisions that includes process design, technical advantage, and the ability to bring a protein technology into real-world use. The show also keeps the audience oriented. It assumes some familiarity with the sector, but it still pauses long enough to explain why the novelty bar, examiner scrutiny, and claim drafting details matter to founders and operators. The episode stays dense. That density works because the conversation stays tied to practical questions, not slogans, and it gives listeners a clear view of how patent strategy intersects with alternative-protein commercialization.

As heard by us

A practical patent discussion for alternative-protein teams trying to turn science into defensible commercial advantage.

This episode treats patents as a working tool for alternative-protein companies, not as legal scenery. It stays on process claims, licensing leverage, and the narrow point where a technical benefit can still persuade an examiner, which gives the discussion a clear commercial…

Read the full review in PlayNext →

Why you'd press play

You need a straight read on patents, process claims, and protection strategy in alternative-protein commercialization.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Protein Production Technology Podcast